From: ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019
Derivation cohort | Validation cohort | P value | Overall | |
---|---|---|---|---|
(N = 176) | (N = 125) | (N = 301) | ||
Outcome | 0.451 | |||
Non-survival, n (%) | 21 (11.9) | 11 (8.8) | 32 (10.6) | |
Survival, n (%) | 155 (88.1) | 114 (91.2) | 269 (89.4) | |
Gender | 0.411 | |||
Female, n (%) | 103 (58.5) | 67 (53.6) | 170 (56.5) | |
Male, n (%) | 73 (41.5) | 58 (46.4) | 131 (43.5) | |
Age, years | 47.0 (33.0–62.0) | 68.0 (62.0–73.0) | < 0.001 | 61.0 (41.0–69.0) |
Comorbidity, n (%) | 37 (21.0) | 60 (48.0) | < 0.001 | 97 (32.2) |
Diabetes, n (%) | 21 (11.9) | 18 (14.4) | 0.602 | 39 (13.0) |
Hypertension, n (%) | 24 (13.6) | 45 (36.0) | < 0.001 | 69 (22.9) |
Coronary heart disease, n (%) | 9 (5.1) | 17 (13.6) | 0.012 | 26 (8.6) |
Illness onset to admission, days | 7.0 (5.0–10.0) | 12.0 (8.0–20.0) | < 0.001 | 9.0 (6.0–14.0) |
Illness onset to discharge or death, days | 21.0 (16.0–26.0) | 38.0 (33.0–46.0) | < 0.001 | 27.0 (19.0–38.0) |